02/08/2026 07:38
|
Medical, Health & Aged Care
Key Facts: VORANIGO® (vorasidenib) is available on the Pharmaceutical Benefits Scheme (PBS) for eligible patients living with Grade 2 IDH-mutant gliomai This is the first new treatment option in...